Literature DB >> 32183887

Outcome of catheter ablation of non-reentrant ventricular arrhythmias in patients with and without structural heart disease.

Ruben Schleberger1, Mario Jularic2, Tim Salzbrunn1, Claudia Hacke3, Jana M Schwarzl1, Boris A Hoffmann4, Daniel Steven5, Stephan Willems2, Marc D Lemoine1, Christian Meyer6,7.   

Abstract

BACKGROUND: Catheter ablation of non-reentrant, commonly termed "idiopathic" ventricular arrhythmias (VA) is highly effective in patients without structural heart disease (SHD). Meanwhile, the outcome of catheter ablation of these arrhythmias in patients with SHD remains unclear. This study sought to characterize the outcome of patients with and without SHD undergoing catheter ablation of non-reentrant VA.
METHODS: In this single-centre study the acute and long-term outcome of 266 consecutive patients undergoing catheter ablation of non-reentrant VA was investigated. In 41.0% of patients a SHD was present (n = 109, 80.7% male, age 59.1 ± 14.7 years), 59.0% had no SHD (n = 157; 44.0% male, age 49.9 ± 16.5 years).
RESULTS: Acute procedural success (absence of spontaneous or provoked VA at the end of procedure and within 48 h after the procedure) was achieved in 89.9% of patients with SHD vs. 94.3% without SHD (p = 0.238). During a mean follow-up of 34.7 ± 15.1 months a repeat catheter ablation was performed in 19.6% of patients with SHD vs. 13.0% without SHD (p = 0.179). Patients with dilated cardiomyopathy (DCM) were the most likely to require a repeat ablation procedure (32.0% of patients with DCM vs. 13.0% without SHD; p = 0.022). Periprocedural complications occurred in 5.5% of patients with SHD vs. 5.7% without SHD (p > 0.999). All complications were managed without sequelae.
CONCLUSIONS: The outcome of catheter ablation of non-reentrant VA in patients with SHD appears good and is comparable to patients without SHD. A slightly higher rate of repeat ablations was observed in patients with DCM.

Entities:  

Keywords:  Idiopathic ventricular tachycardia; Non-reentrant ventricular tachycardia; Structural heart disease; VT ablation; Ventricular arrhythmia

Year:  2020        PMID: 32183887     DOI: 10.1186/s40001-020-0400-y

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  3 in total

1.  Spatial correction improves accuracy of catheter positioning during ablation of premature ventricular contractions: differences between ventricular outflow tracts and other localizations.

Authors:  M Nies; R Schleberger; L Dinshaw; N Klatt; P Muenkler; C Jungen; L Rottner; M D Lemoine; B Reißmann; A Rillig; A Metzner; P Kirchhof; C Meyer
Journal:  BMC Cardiovasc Disord       Date:  2022-07-13       Impact factor: 2.174

2.  Bipolar ablation of therapy-refractory ventricular arrhythmias: application of a dedicated approach.

Authors:  Shinwan Kany; Fares Alexander Alken; Ruben Schleberger; Jakub Baran; Armin Luik; Annika Haas; Elena Ene; Thomas Deneke; L Dinshaw; Andreas Rillig; Andreas Metzner; Bruno Reissmann; Hisaki Makimoto; Tilko Reents; Miruna Andrea Popa; Isabel Deisenhofer; Roman Piotrowski; Piotr Kulakowski; Paulus Kirchhof; Katharina Scherschel; Christian Meyer
Journal:  Europace       Date:  2022-07-15       Impact factor: 5.486

3.  Ablation of Outflow Tract Arrhythmias in Patients With and Without Structural Heart Disease-A Comparative Analysis.

Authors:  Ruben Schleberger; Jan Riess; Anika Brauer; Hans O Pinnschmidt; Laura Rottner; Fabian Moser; Julia Moser; Shinwan Kany; Ilaria My; Marc D Lemoine; Bruno Reissmann; Christian Meyer; Andreas Metzner; Feifan Ouyang; Paulus Kirchhof; Andreas Rillig
Journal:  Front Cardiovasc Med       Date:  2022-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.